Metastatic thoracic and lumbar intramedullary and extramedullary Ewing's sarcoma: a rare case report and literature review. Issue 8 (August 2022)

• Record Type: Journal Article
• Authors: Mousavi, Seyed Reza; Farrokhi, Majid Reza; Eghbal, Keyvan; Dehghanian, Amirreza; Rezvani, Alireza; Ghaffarpasand, Fariborz
• Is Part Of: Journal of international medical research. Volume 50:Issue 8(2022)
• Publication Date: 2022-08
• Subjects: Ewing sarcoma -- intramedullary -- extramedullary -- metastasis -- surgical resection -- adjuvant chemotherapy -- rare; Medicine -- Periodicals; Pharmacology -- Periodicals; 610.5
• DOI: 10.1177/03000605221108095
• Languages: English
• ISSNs: 0300-0605

Abstract

Ewing sarcoma (ES) is a highly aggressive bone and soft tissue tumor that occurs mainly in young children and adolescents and is associated with primary and metastatic disease. Intramedullary ES (either primary or secondary) is rare, and the ideal management remains inconclusive. We herein report intramedullary and extramedullary metastatic ES in a single patient. A 46-year-old woman was referred to our outpatient clinic from the oncology clinic with progressive paraparesis and paresthesia for 1 week prior to presentation. She had developed left clavicular ES 2 years earlier for which surgery and chemoradiotherapy had been performed. At the present evaluation, she was diagnosed with intramedullary thoracic and lumbar extradural masses. Thoracic surgery was performed, and a biopsy of the lesion was obtained. The diagnosis of ES was confirmed histopathologically, and she underwent adjuvant chemotherapy. Her neurological status did not improve after surgery, and she underwent rehabilitation and physical therapy. The lumbar lesion resolved with chemotherapy. Metastasis of ES to the spinal cord, especially intramedullary lesions, is extremely rare, and there is no standard management guideline. However, surgical decompression and adjuvant chemotherapy are the main treatments in these cases.